The International Vaccine Institute (IVI), an international organization devoted to the development and introduction of new vaccines for global public health, is hosting the 18th International Vaccinology Course (IVC) at IVI Headquarters in Seoul from September 3 to 7.
This annual course provides vaccine professionals, especially from developing countries, with introductory training in vaccine discovery, development, and delivery, in order to increase developing countries’ capacity in vaccines and vaccination. The course has trained over 1,200 professionals in the past 17 years. This year’s course brings together 120 international participants from 19 countries, including trainees and faculty from Korea, the U.S., India, the U.K., Switzerland, and Singapore. The trainees include 12 professionals from low- and middle-income countries who were awarded travel fellowships, made possible via donor and sponsor support.
The five-day course provides a comprehensive overview of vaccinology by leading experts in the field. Beginning with a refresher in epidemiology and immunology, the course moves through the vaccine development spectrum: from applied topics in vaccine discovery, through clinical vaccine development, and the introduction of new vaccines into national vaccination programs.
More than 30 vaccine experts from IVI; the World Health Organization; research institutes, including the U.S. National Institutes of Health; industry; universities; and non-profit organizations serve as faculty members. They include: Prof. Hazel Dockerell (London School of Hygiene & Tropical Medicine), Prof. Stanley Plotkin (University of Pennsylvania), Dr. Barney Graham (US NIH), Dr. Randy Schoepp (USAMRID), Prof. Andy Pollard (University of Oxford), and Dr. Eric Mintz (US CDC). The course will include a lecture on the ‘Ending Cholera: Global Roadmap 2030’ initiative (Lorenzo Pezzoli of the WHO) to inform and update on the ambitious WHO/UNICEF strategy to reduce cholera deaths by 90 percent by 2030.
This year’s course also features a welcome speech by Dr. Youngmee Jee from the National Institute of Health under the Korea Centers for Disease Control and Prevention (member of WHO’s Strategic Advisory Group of Experts on Immunization), and plenary sessions on the Future of Vaccines (Dr. Plotkin) and Structure-based Vaccine Design for Respiratory Viruses (Dr. Graham) on Friday. Participants may also choose to visit GE’s Fast Trak Training
“This year’s course has brought together more training participants than ever, which highlights the importance of increasing global capacity in vaccines and vaccine development,” said IVI Director General Dr. Jerome Kim, “We will continue to provide quality training programs to help developing countries increase capacity in vaccines and immunization.”
This year’s program is supported GlaxoSmithKlein, EuBiologics, Sky 72 Golf Club, Seoul Metropolitan City, and Community Chest of Korea-Incheon.
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 30 countries throughout Asia, Africa and Latin America on vaccines against diarrheal infections, bacterial meningitis and pneumonia, as well as Japanese encephalitis and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit www.ivi.int.
Tae Kyung Byun
Acting Head of Communications, IVI
Phone: +82-2-872-2801 (Ext. 159)